Two eminent BHP researchers have been named among 50 of the UK’s leading figures in biomedical and health sciences, through election to the esteemed Academy of Medical Sciences Fellowship.
Professors Gavin Perkins and Arri Coomarasamy have been selected for their outstanding contributions to advancing medical science, cutting edge research discoveries, and translating developments into benefits for patients and wider society. Many of the new Fellows have also made a contribution to medical science through outstanding leadership, public engagement and supporting the career advancement of junior trainees.
Professor Gavin Perkins is a Critical Care Consultant at BHP founder member University Hospitals Birmingham NHS Foundation Trust, and Director of the Warwick Clinical Trials Unit. He said:
“I am delighted to be given the opportunity to become a Fellow of the Academy of Medical Sciences.
“My research tackles some of the most challenging research questions in emergency and critical care medicine. My focus is on improving patient care and outcomes from the scene of the emergency through to care in the intensive care unit. Leading Warwick Clinical Trials Unit provides an excellent environment to deliver high quality, multi-disciplinary research.
“Joining the Academy provides the opportunity to collaborate with some of the greatest minds in health science for the benefit of society.”
Professor Arri Coomarasamy of the Institute of Metabolism and Systems Research at BHP founder member the University of Birmingham, commented:
“I am honoured to have been elected as a Fellow of the Academy. The Academy is at the forefront of advancing medical science, which directly or indirectly benefits patient care.
“What particularly draws me to the Academy is the investment it makes in junior researchers. They will solve the problems of tomorrow in an ever-changing world and their breakthroughs will shape our world. I am looking forward to contributing to the great work the Academy does.”
Professor Coomarasamy also leads a research group at the forefront of early pregnancy care, reproductive medicine and global women’s health, and is Director of the Tommy’s National Centre for Miscarriage Research. His portfolio includes leading numerous national and international multicentre randomised controlled trials and he has published over 160 medical articles in high impact journals, including five in the New England Journal of Medicine.
Professor Sir Robert Lechler PMedSci, President of the Academy of Medical Sciences said: “The Academy’s Fellowship is a unique assembly of the finest minds in biomedical and health research, from across the UK and beyond.
“Our Fellows are at the centre of all that we do, from supporting early career researchers via our hugely popular mentorship programme to incorporating public and patient views into health research. Their collective wisdom is a national asset to guide research and policy aimed at tackling pressing health challenges.
“It brings me great pleasure to congratulate the new Fellows, each of whom has pushed the boundaries of their individual research field. I am always delighted to see the Fellowship expand, adding fresh talent to our invaluable pool of high quality guidance, advice and expertise.”
The new Fellows will be formally admitted to the Academy at a ceremony on 26 June 2019.